255 related articles for article (PubMed ID: 26416248)
1. RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.
Bozza WP; Zhang Y; Hallett K; Rivera Rosado LA; Zhang B
Oncotarget; 2015 Oct; 6(32):32723-36. PubMed ID: 26416248
[TBL] [Abstract][Full Text] [Related]
2. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
Sun J; Barbieri JT
J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling.
DerMardirossian C; Rocklin G; Seo JY; Bokoch GM
Mol Biol Cell; 2006 Nov; 17(11):4760-8. PubMed ID: 16943322
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
[TBL] [Abstract][Full Text] [Related]
5. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
Zhang B; Zhang Y; Dagher MC; Shacter E
Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
[TBL] [Abstract][Full Text] [Related]
6. RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility.
Yu J; Zhang D; Liu J; Li J; Yu Y; Wu XR; Huang C
J Biol Chem; 2012 Apr; 287(17):13752-60. PubMed ID: 22393046
[TBL] [Abstract][Full Text] [Related]
7. A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.
Ahmad Mokhtar AMB; Ahmed SBM; Darling NJ; Harris M; Mott HR; Owen D
Biochemistry; 2021 May; 60(19):1533-1551. PubMed ID: 33913706
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of regulation of RhoA GTPase by phosphorylation of RhoGDI.
Sinha K; Kumawat A; Jang H; Nussinov R; Chakrabarty S
Biophys J; 2024 Jan; 123(1):57-67. PubMed ID: 37978802
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI.
Golovanov AP; Chuang TH; DerMardirossian C; Barsukov I; Hawkins D; Badii R; Bokoch GM; Lian LY; Roberts GC
J Mol Biol; 2001 Jan; 305(1):121-35. PubMed ID: 11114252
[TBL] [Abstract][Full Text] [Related]
10. Disruption of RhoGDI and RhoA regulation by a Rac1 specificity switch mutant.
Wong KW; Mohammadi S; Isberg RR
J Biol Chem; 2006 Dec; 281(52):40379-88. PubMed ID: 17074770
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3τ promotes breast cancer invasion and metastasis by inhibiting RhoGDIα.
Xiao Y; Lin VY; Ke S; Lin GE; Lin FT; Lin WC
Mol Cell Biol; 2014 Jul; 34(14):2635-49. PubMed ID: 24820414
[TBL] [Abstract][Full Text] [Related]
12. Morphological and proliferative abnormalities in renal mesangial cells lacking RhoGDI.
Bielek H; Anselmo A; Dermardirossian C
Cell Signal; 2009 Dec; 21(12):1974-83. PubMed ID: 19765647
[TBL] [Abstract][Full Text] [Related]
13. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.
Schunke D; Span P; Ronneburg H; Dittmer A; Vetter M; Holzhausen HJ; Kantelhardt E; Krenkel S; Müller V; Sweep FC; Thomssen C; Dittmer J
Cancer Res; 2007 Nov; 67(22):10694-702. PubMed ID: 18006811
[TBL] [Abstract][Full Text] [Related]
15. An activating mutant of Rac1 that fails to interact with Rho GDP-dissociation inhibitor stimulates membrane ruffling in mammalian cells.
Gandhi PN; Gibson RM; Tong X; Miyoshi J; Takai Y; Konieczkowski M; Sedor JR; Wilson-Delfosse AL
Biochem J; 2004 Mar; 378(Pt 2):409-19. PubMed ID: 14629200
[TBL] [Abstract][Full Text] [Related]
16. MLL regulates the actin cytoskeleton and cell migration by stabilising Rho GTPases via the expression of RhoGDI1.
Chinchole A; Lone KA; Tyagi S
J Cell Sci; 2022 Oct; 135(20):. PubMed ID: 36111497
[TBL] [Abstract][Full Text] [Related]
17. An activating mutant of Cdc42 that fails to interact with Rho GDP-dissociation inhibitor localizes to the plasma membrane and mediates actin reorganization.
Gibson RM; Gandhi PN; Tong X; Miyoshi J; Takai Y; Konieczkowski M; Sedor JR; Wilson-Delfosse AL
Exp Cell Res; 2004 Dec; 301(2):211-22. PubMed ID: 15530857
[TBL] [Abstract][Full Text] [Related]
18. RhoGDI: multiple functions in the regulation of Rho family GTPase activities.
Dovas A; Couchman JR
Biochem J; 2005 Aug; 390(Pt 1):1-9. PubMed ID: 16083425
[TBL] [Abstract][Full Text] [Related]
19. Role of Rho GTPases in breast cancer.
Tang Y; Olufemi L; Wang MT; Nie D
Front Biosci; 2008 Jan; 13():759-76. PubMed ID: 17981586
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.
Zhao L; Wang H; Li J; Liu Y; Ding Y
J Proteome Res; 2008 Sep; 7(9):3994-4003. PubMed ID: 18651761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
